No images? Click here
We believe Engineering Biology has the potential to transform human and planetary health. Every other month we'll be sharing non-obvious insights from innovators in our network, portfolio company news, and our perspective on where we're headed next.
In this edition:
- Jennifer Doudna Shares How COVID-19 is Spurring Science to Accelerate
- Stephane Bancel Explains How Moderna Built Platform into its DNA
- Ursheet Shares POV on Post-Pandemic Areas of Opportunity and Engineering Biology Company Building
- Mammoth Biosciences' Recent Milestones: Developing a Rapid COVID-19 Test, Partnering with GSK, and More
How COVID-19 is Spurring Science to Accelerate
Jennifer Doudna shares her perspective on the change underway for scientists, dissemination of research, and forms of collaboration.
Innovator Spotlight: Moderna CEO Stephane Bancel
Stephane Bancel, Moderna’s founding CEO, reflects on the key drivers that enabled Moderna to grow into a stand-alone leader.
Three Post-Pandemic Areas of Opportunity in Digital Health & Genomics
Ursheet shares areas of opportunity for entrepreneurs to leverage behavior trends, scientific breakthroughs, and innovative business models to build big companies.
Engineering Biology Company Building
Ursheet shares his thoughts on investing, what he looks for in a founder, and the impact marketing can have on a healthcare startup.
Portfolio Spotlight: Mammoth Biosciences
In 2018, Mayfield partnered with the Mammoth team on their mission to build a new-age CRISPR company, leading the Series A investment. Here are some of the big milestones the company has achieved in 2020.
